Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O
Am J Surg. 1975 Sep;130(3):296-302. doi: 10.1016/0002-9610(75)90389-x.
Portal branch ligation, a new surgical treatment for unresectable carcinoma of the liver, was performed in twenty patients. All the patients tolerated the procedure, and morbidity and mortality were minimal, even in patients in poor general condition. The responses to ligation differed considerably, but significant palliation was attained in some patients and one survived six years. The effect of portal branch ligation on the tumor appears to be closely related to the degree of tumor vascularity, tumor malignancy, and portal circulatory disturbances such as cirrhosis, portal hypertension, or portal thrombosis. We believe that the present procedure can be recommended for clinical application in some patients with unresectable carcinoma of the liver.
门静脉分支结扎术是一种针对无法切除的肝癌的新型外科治疗方法,已应用于20例患者。所有患者均耐受该手术,发病率和死亡率极低,即使是一般状况较差的患者也是如此。结扎后的反应差异很大,但部分患者获得了显著的症状缓解,其中1例存活了6年。门静脉分支结扎术对肿瘤的影响似乎与肿瘤血管化程度、肿瘤恶性程度以及门静脉循环障碍(如肝硬化、门静脉高压或门静脉血栓形成)密切相关。我们认为,本手术可推荐用于某些无法切除的肝癌患者的临床治疗。